{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:33:17Z","timestamp":1787257997529,"version":"build-2736575974"},"reference-count":102,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Faculty of Pharmaceutical Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1111\/jcpt.12318","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T13:08:41Z","timestamp":1439816921000},"page":"508-516","source":"Crossref","is-referenced-by-count":22,"title":["Preserving the peritoneal membrane in long-term peritoneal dialysis patients"],"prefix":"10.1155","volume":"40","author":[{"given":"P.","family":"Ditsawanon","sequence":"first","affiliation":[{"name":"Bioactive Resources for Innovative Clinical Applications Research Unit; Department of Pharmacy Practice; Faculty of Pharmaceutical Sciences; Chulalongkorn University; Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aramwit","sequence":"additional","affiliation":[{"name":"Bioactive Resources for Innovative Clinical Applications Research Unit; Department of Pharmacy Practice; Faculty of Pharmaceutical Sciences; Chulalongkorn University; Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"10.1111\/jcpt.12318-BIB0001|jcpt12318-cit-0001","unstructured":"ESRD patients in 2013 A global perspective 2014 www.vision-fmc.com\/files\/ESRD_Patients_in_2013.pdf"},{"key":"10.1111\/jcpt.12318-BIB0002|jcpt12318-cit-0002","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/archinternmed.2010.352","article-title":"Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease","volume":"171","author":"Mehrotra","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12318-BIB0003|jcpt12318-cit-0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.2-273.v1","article-title":"Economic evaluations of peritoneal dialysis and hemodialysis: 2004-2012","volume":"2","author":"Liu","year":"2013","journal-title":"F1000Res"},{"key":"10.1111\/jcpt.12318-BIB0004|jcpt12318-cit-0004","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/oxfordjournals.ndt.a027318","article-title":"Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis","volume":"11","author":"Davies","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1111\/jcpt.12318-BIB0005|jcpt12318-cit-0005","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1177\/089686080702702s15","article-title":"Peritoneal fibrosis intervention","volume":"27","author":"Kaneko","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0006|jcpt12318-cit-0006","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/089686080902900604","article-title":"Factors contributing to peritoneal tissue remodeling in peritoneal dialysis","volume":"29","author":"Schilte","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0007|jcpt12318-cit-0007","doi-asserted-by":"crossref","first-page":"912595","DOI":"10.1155\/2012\/912595","article-title":"Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis","volume":"2012","author":"Baroni","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1111\/jcpt.12318-BIB0008|jcpt12318-cit-0008","doi-asserted-by":"crossref","first-page":"434608","DOI":"10.4061\/2011\/434608","article-title":"Peritoneal Dialysis Drop-out: Causes and Prevention Strategies","volume":"2011","author":"Chaudhary","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0009|jcpt12318-cit-0009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-0-387-78940-8_5","volume-title":"Nolph and Gokal's textbook of peritoneal dialysis","author":"Gotloib","year":"2009","edition":"3"},{"key":"10.1111\/jcpt.12318-BIB0010|jcpt12318-cit-0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1561-5413(09)60096-X","article-title":"Peritoneal fibrosis-future prevention strategies","volume":"5","author":"Yung","year":"2003","journal-title":"Hong Kong J Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0011|jcpt12318-cit-0011","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/978-0-387-78940-8_27","volume-title":"Nolph and Gokal's textbook of peritoneal dialysis","author":"Devuyst","year":"2009","edition":"3"},{"key":"10.1111\/jcpt.12318-BIB0012|jcpt12318-cit-0012","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0013|jcpt12318-cit-0013","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Yanez-Mo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1111\/jcpt.12318-BIB0014|jcpt12318-cit-0014","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1681\/ASN.2013101079","article-title":"Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury","volume":"25","author":"Chen","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0015|jcpt12318-cit-0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1525-139X.2008.00425.x","article-title":"Peritoneal membrane structural and functional changes during peritoneal dialysis","volume":"21","author":"Goffin","year":"2008","journal-title":"Semin Dial"},{"key":"10.1111\/jcpt.12318-BIB0016|jcpt12318-cit-0016","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/17.4.548","article-title":"New insights in the molecular mechanisms regulating peritoneal permeability","volume":"17","author":"Devuyst","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0017|jcpt12318-cit-0017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10157-011-0533-y","article-title":"Mechanisms and interventions in peritoneal fibrosis","volume":"16","author":"Tomino","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0018|jcpt12318-cit-0018","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.87","article-title":"Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury","author":"Terabayashi","year":"2015","journal-title":"Lab Invest"},{"key":"10.1111\/jcpt.12318-BIB0019|jcpt12318-cit-0019","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1681\/ASN.2013070799","article-title":"A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis","volume":"26","author":"Busnadiego","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0020|jcpt12318-cit-0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/089686089601600324","article-title":"Physiological approaches to increase biocompatibility of peritoneal dialysis","volume":"16","author":"Veech","year":"1996","journal-title":"Perit Dial Int"},{"issue":"Suppl 2","key":"10.1111\/jcpt.12318-BIB0021|jcpt12318-cit-0021","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1177\/089686080002002S06","article-title":"Chemistry of glucose and biochemical pathways of biological interest","volume":"20","author":"Pischetsrieder","year":"2000","journal-title":"Perit Dial Int"},{"issue":"Suppl 2","key":"10.1111\/jcpt.12318-BIB0022|jcpt12318-cit-0022","first-page":"S87","article-title":"Studying the effects of new peritoneal dialysis solutions on the peritoneum","volume":"27","author":"Chan","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0023|jcpt12318-cit-0023","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1523-1755.2002.00135.x","article-title":"Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes","volume":"61","author":"Miyata","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0024|jcpt12318-cit-0024","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/089686080802800214","article-title":"The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial","volume":"28","author":"Choi","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0025|jcpt12318-cit-0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","article-title":"The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane","volume":"66","author":"Williams","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0026|jcpt12318-cit-0026","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08860220701808384","article-title":"The alteration of dialysate cancer antigen\u00a0125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability","volume":"30","author":"Theodoridis","year":"2008","journal-title":"Ren Fail"},{"key":"10.1111\/jcpt.12318-BIB0027|jcpt12318-cit-0027","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gfq357","article-title":"Low-GDP peritoneal dialysis fluid (\u2018balance\u2019) has less impact in\u00a0vitro and ex\u00a0vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid","volume":"26","author":"Bajo","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0028|jcpt12318-cit-0028","first-page":"58","article-title":"Effects of low-glucose degradation product solution on peritoneal membrane characteristics in peritoneal dialysis patients: a 3-year follow-up study","volume":"8","author":"Park","year":"2014","journal-title":"Iran J Kidney Dis"},{"key":"10.1111\/jcpt.12318-BIB0029|jcpt12318-cit-0029","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1093\/ndt\/gfs314","article-title":"The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial","volume":"27","author":"Johnson","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0030|jcpt12318-cit-0030","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2011121201","article-title":"Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes","volume":"23","author":"Johnson","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0031|jcpt12318-cit-0031","doi-asserted-by":"publisher","first-page":"CD007554","DOI":"10.1002\/14651858.CD007554.pub2","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"3","author":"Cho","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12318-BIB0032|jcpt12318-cit-0032","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3747\/pdi.2012.00331","article-title":"Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials","volume":"34","author":"Seo","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0033|jcpt12318-cit-0033","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ki.1989.109","article-title":"CAPD with an amino acid dialysis solution: a long-term, cross-over study","volume":"35","author":"Bruno","year":"1989","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1111\/jcpt.12318-BIB0034|jcpt12318-cit-0034","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1177\/089686080502503S16","article-title":"Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious","volume":"25","author":"Poole","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0035|jcpt12318-cit-0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrneph.2012.13","article-title":"An update on peritoneal dialysis solutions","volume":"8","author":"Garcia-Lopez","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0036|jcpt12318-cit-0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1797.2003.00117.x","article-title":"Recommendations for the use of icodextrin in peritoneal dialysis patients","volume":"8","author":"Johnson","year":"2003","journal-title":"Nephrology"},{"key":"10.1111\/jcpt.12318-BIB0037|jcpt12318-cit-0037","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ki.1994.300","article-title":"A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis","volume":"46","author":"Mistry","year":"1994","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0038|jcpt12318-cit-0038","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/089686080902900402","article-title":"Icodextrin metabolites in peritoneal dialysis","volume":"29","author":"Garcia-Lopez","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0039|jcpt12318-cit-0039","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/089686080002000627","article-title":"Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex\u00a0vivo","volume":"20","author":"Bajo","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0040|jcpt12318-cit-0040","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ASN.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0041|jcpt12318-cit-0041","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.02950509","article-title":"Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid","volume":"4","author":"Lin","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0042|jcpt12318-cit-0042","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/ajkd.2002.32009","article-title":"Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis","volume":"39","author":"Plum","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jcpt.12318-BIB0043|jcpt12318-cit-0043","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.10041110","article-title":"Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial","volume":"6","author":"Takatori","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0044|jcpt12318-cit-0044","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3346\/jkms.2014.29.9.1217","article-title":"Benefits of a Continuous Ambulatory Peritoneal Dialysis (CAPD) Technique with One Icodextrin-Containing and Two Biocompatible Glucose-Containing Dialysates for Preservation of Residual Renal Function and Biocompatibility in Incident CAPD Patients","volume":"29","author":"Yoon","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1111\/jcpt.12318-BIB0045|jcpt12318-cit-0045","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ki.1997.190","article-title":"TGF-beta in kidney fibrosis: a target for gene therapy","volume":"51","author":"Border","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0046|jcpt12318-cit-0046","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/039139880402701003","article-title":"Inhibition of the effect of high glucose on the expression of Smad in human peritoneal mesothelial cells","volume":"27","author":"Yao","year":"2004","journal-title":"Int J Artif Organs"},{"key":"10.1111\/jcpt.12318-BIB0047|jcpt12318-cit-0047","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cyto.2010.11.004","article-title":"Valsartan decreases TGF-beta1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats","volume":"53","author":"Subeq","year":"2011","journal-title":"Cytokine"},{"key":"10.1111\/jcpt.12318-BIB0048|jcpt12318-cit-0048","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/039139880502800212","article-title":"Effect of valsartan versus lisinopril on peritoneal sclerosis in rats","volume":"28","author":"Duman","year":"2005","journal-title":"Int J Artif Organs"},{"key":"10.1111\/jcpt.12318-BIB0049|jcpt12318-cit-0049","first-page":"31","article-title":"Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum","volume":"20","author":"Duman","year":"2004","journal-title":"Adv Perit Dial"},{"key":"10.1111\/jcpt.12318-BIB0050|jcpt12318-cit-0050","doi-asserted-by":"crossref","first-page":"e36268","DOI":"10.1371\/journal.pone.0036268","article-title":"Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats","volume":"7","author":"Perez-Martinez","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12318-BIB0051|jcpt12318-cit-0051","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2362.2010.02264.x","article-title":"Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats","volume":"40","author":"Ke","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/jcpt.12318-BIB0052|jcpt12318-cit-0052","doi-asserted-by":"crossref","first-page":"F1084","DOI":"10.1152\/ajprenal.00565.2007","article-title":"Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model","volume":"294","author":"Nishimura","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/jcpt.12318-BIB0053|jcpt12318-cit-0053","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/089686080702700413","article-title":"Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients","volume":"27","author":"Kolesnyk","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0054|jcpt12318-cit-0054","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1440-1797.2009.01162.x","article-title":"Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients","volume":"15","author":"Jing","year":"2010","journal-title":"Nephrology"},{"key":"10.1111\/jcpt.12318-BIB0055|jcpt12318-cit-0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/1744-9987.12091","article-title":"Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients","volume":"17","author":"Tro\u0161t Rupnik","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1111\/jcpt.12318-BIB0056|jcpt12318-cit-0056","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/ndt\/gfn421","article-title":"A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients","volume":"24","author":"Kolesnyk","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0057|jcpt12318-cit-0057","first-page":"5","article-title":"Effects of spironolactone on residual renal function and peritoneal function in peritoneal dialysis patients","volume":"30","author":"Yelken","year":"2014","journal-title":"Adv Perit Dial"},{"key":"10.1111\/jcpt.12318-BIB0058|jcpt12318-cit-0058","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1681\/ASN.2013030273","article-title":"Long-term effects of spironolactone in peritoneal dialysis patients","volume":"25","author":"Ito","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0059|jcpt12318-cit-0059","first-page":"537","volume-title":"Medical biochemistry","author":"Sheriff","year":"2004","edition":"1"},{"key":"10.1111\/jcpt.12318-BIB0060|jcpt12318-cit-0060","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1093\/ndt\/gfp440","article-title":"Altering peritoneal membrane function: removing the GAG?","volume":"24","author":"Fraser","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0061|jcpt12318-cit-0061","doi-asserted-by":"crossref","first-page":"180594","DOI":"10.1155\/2011\/180594","article-title":"Pathophysiology of the peritoneal membrane during peritoneal dialysis: the role of hyaluronan","volume":"2011","author":"Yung","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1111\/jcpt.12318-BIB0062|jcpt12318-cit-0062","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000078463","article-title":"Effect of hyaluronan-supplemented dialysate on in\u00a0vitro function of human peritoneal mesothelial cells","volume":"24","author":"Breborowicz","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0063|jcpt12318-cit-0063","first-page":"491","article-title":"Agents preventing decrease in ultrafiltration in a rat model with peritoneal hyperpermeability","volume":"37","author":"Suyama","year":"1995","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"10.1111\/jcpt.12318-BIB0064|jcpt12318-cit-0064","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/089686080502500416","article-title":"Low molecular weight heparin improves peritoneal ultrafiltration and blocks complement and coagulation","volume":"25","author":"Bazargani","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0065|jcpt12318-cit-0065","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ndt\/gfh065","article-title":"Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients","volume":"19","author":"Sjoland","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0066|jcpt12318-cit-0066","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(99)70264-7","article-title":"Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis","volume":"33","author":"Fracasso","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jcpt.12318-BIB0067|jcpt12318-cit-0067","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1159\/000113011","article-title":"Anti-inflammatory effect of sulodexide during acute peritonitis in rats","volume":"25","author":"Karon","year":"2007","journal-title":"Blood Purif"},{"key":"10.1111\/jcpt.12318-BIB0068|jcpt12318-cit-0068","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/gfr370","article-title":"Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion","volume":"27","author":"Pletinck","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0069|jcpt12318-cit-0069","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(95)91506-0","article-title":"Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis","volume":"346","author":"Bazzato","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12318-BIB0070|jcpt12318-cit-0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/089686080302300615","article-title":"Effect of oral treatment with the glycosaminoglycan sulodexide on peritoneal transport in CAPD patients","volume":"23","author":"Fracasso","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0071|jcpt12318-cit-0071","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitine-metabolism and functions","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol Rev"},{"key":"10.1111\/jcpt.12318-BIB0072|jcpt12318-cit-0072","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/039139880502800215","article-title":"Prevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in\u00a0vitro and in rabbits)","volume":"28","author":"Gaggiotti","year":"2005","journal-title":"Int J Artif Organs"},{"key":"10.1111\/jcpt.12318-BIB0073|jcpt12318-cit-0073","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/ki.2011.117","article-title":"L-carnitine is an osmotic agent suitable for peritoneal dialysis","volume":"80","author":"Bonomini","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0074|jcpt12318-cit-0074","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089686080902900216","article-title":"Evaluation of taurine as an osmotic agent for peritoneal dialysis solution","volume":"29","author":"Nishimura","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0075|jcpt12318-cit-0075","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/labinvest.2010.111","article-title":"PPAR-gamma agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage","volume":"90","author":"Sandoval","year":"2010","journal-title":"Lab Invest"},{"key":"10.1111\/jcpt.12318-BIB0076|jcpt12318-cit-0076","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1440-1797.2006.00654.x","article-title":"Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells","volume":"11","author":"Peng","year":"2006","journal-title":"Nephrology"},{"key":"10.1111\/jcpt.12318-BIB0077|jcpt12318-cit-0077","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3892\/mmr.2013.1309","article-title":"Pioglitazone inhibits high glucose-induced synthesis of extracellular matrix by NF-kappaB and AP-1 pathways in rat peritoneal mesothelial cells","volume":"7","author":"Zhou","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1111\/jcpt.12318-BIB0078|jcpt12318-cit-0078","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1523-1755.2001.00933.x","article-title":"Dipyridamole inhibits TGF-beta-induced collagen gene expression in human peritoneal mesothelial cells","volume":"60","author":"Hung","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0079|jcpt12318-cit-0079","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1046\/j.1523-1755.2001.00749.x","article-title":"Dipyridamole inhibits human peritoneal mesothelial cell proliferation in\u00a0vitro and attenuates rat peritoneal fibrosis in\u00a0vivo","volume":"59","author":"Hung","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0080|jcpt12318-cit-0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cellbi.2006.11.018","article-title":"A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells","volume":"31","author":"Liu","year":"2007","journal-title":"Cell Biol Int"},{"key":"10.1111\/jcpt.12318-BIB0081|jcpt12318-cit-0081","doi-asserted-by":"crossref","first-page":"e44765","DOI":"10.1371\/journal.pone.0044765","article-title":"Fibrin-Induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline","volume":"7","author":"Fang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12318-BIB0082|jcpt12318-cit-0082","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1046\/j.1523-1755.2000.00123.x","article-title":"Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: effects on TGF-beta","volume":"57","author":"Fang","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0083|jcpt12318-cit-0083","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ndt\/gfg141","article-title":"Pentoxifylline modulates intracellular signalling of TGF-beta in cultured human peritoneal mesothelial cells: implications for prevention of encapsulating peritoneal sclerosis","volume":"18","author":"Hung","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 3","key":"10.1111\/jcpt.12318-BIB0084|jcpt12318-cit-0084","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1177\/089686080102103S07","article-title":"Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor beta1 and fibronectin by human peritoneal mesothelial cells","volume":"21","author":"Yung","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0085|jcpt12318-cit-0085","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/sj.ki.5001506","article-title":"Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane","volume":"69","author":"Noh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0086|jcpt12318-cit-0086","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/ndt\/gfk051","article-title":"Diltiazem suppresses collagen synthesis and IL-1beta-induced TGF-beta1 production on human peritoneal mesothelial cells","volume":"21","author":"Fang","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0087|jcpt12318-cit-0087","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ndt\/gfp618","article-title":"BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure","volume":"25","author":"Loureiro","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12318-BIB0088|jcpt12318-cit-0088","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1681\/ASN.2008040424","article-title":"HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium","volume":"20","author":"Yu","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0089|jcpt12318-cit-0089","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1582-4934.2011.01493.x","article-title":"Rapamycin inhibits transforming growth factor beta-induced peritoneal angiogenesis by blocking the secondary hypoxic response","volume":"16","author":"Sekiguchi","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1111\/jcpt.12318-BIB0090|jcpt12318-cit-0090","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1681\/ASN.V1482109","article-title":"Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane","volume":"14","author":"Vriese","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0091|jcpt12318-cit-0091","doi-asserted-by":"crossref","first-page":"e109628","DOI":"10.1371\/journal.pone.0109628","article-title":"The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12318-BIB0092|jcpt12318-cit-0092","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/0886022X.2010.508859","article-title":"Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis","volume":"32","author":"Yenicerioglu","year":"2010","journal-title":"Ren Fail"},{"key":"10.1111\/jcpt.12318-BIB0093|jcpt12318-cit-0093","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/jpet.114.215228","article-title":"Suramin inhibits the development and progression of peritoneal fibrosis","volume":"351","author":"Xiong","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jcpt.12318-BIB0094|jcpt12318-cit-0094","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2013101128","article-title":"Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelial cells exposed to peritoneal dialysis fluids","volume":"25","author":"Herzog","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0095|jcpt12318-cit-0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3747\/pdi.2011.00234","article-title":"22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model","volume":"33","author":"Hirose","year":"2013","journal-title":"Perit Dial Int"},{"key":"10.1111\/jcpt.12318-BIB0096|jcpt12318-cit-0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000357156","article-title":"Paricalcitol ameliorates epithelial-to-mesenchymal transition in the peritoneal mesothelium","volume":"126","author":"Kang","year":"2014","journal-title":"Nephron Exp Nephrol"},{"key":"10.1111\/jcpt.12318-BIB0097|jcpt12318-cit-0097","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cyto.2013.10.003","article-title":"Calcitriol decreases TGF-beta1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats","volume":"65","author":"Lee","year":"2014","journal-title":"Cytokine"},{"key":"10.1111\/jcpt.12318-BIB0098|jcpt12318-cit-0098","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/0886022X.2013.808565","article-title":"Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis","volume":"35","author":"Peng","year":"2013","journal-title":"Ren Fail"},{"key":"10.1111\/jcpt.12318-BIB0099|jcpt12318-cit-0099","doi-asserted-by":"crossref","first-page":"12959","DOI":"10.3390\/ijms150712959","article-title":"Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-beta1 (TGF-beta1) pathway in rats submitted to peritoneal dialysis","volume":"15","author":"Li","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1111\/jcpt.12318-BIB0100|jcpt12318-cit-0100","doi-asserted-by":"crossref","first-page":"e61165","DOI":"10.1371\/journal.pone.0061165","article-title":"Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis","volume":"8","author":"Loureiro","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12318-BIB0101|jcpt12318-cit-0101","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ki.2013.81","article-title":"Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling","volume":"84","author":"Ueno","year":"2013","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12318-BIB0102|jcpt12318-cit-0102","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000345726","article-title":"Cannabinoid receptors as therapeutic targets for dialysis-induced peritoneal fibrosis","volume":"37","author":"Yang","year":"2013","journal-title":"Am J Nephrol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12318","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12318","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12318\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:59Z","timestamp":1671818759000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12318","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,17]]}}}